When will xarelto 20 mg go generic?

Xarelto 20 mg Generic Availability Timeline

The generic version of Xarelto, manufactured by Bayer and Janssen Pharmaceuticals, is already available in the United States [1]. In February 2020, the FDA approved the first generic versions of Xarelto (rivaroxaban) for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation [2]. The approved generic versions are manufactured by multiple pharmaceutical companies, including Mylan and Teva [3].

Why Did Generic Versions Become Available So Quickly?

Bayer and Janssen Pharmaceuticals did not aggressively challenge the generic versions of Xarelto in court, unlike other pharmaceutical companies. As a result, generic versions of the medication were approved and launched quickly, without significant patent-related delays [4].

Generic Pricing and Availability

Generic versions of Xarelto have become available without exclusivity, making the medication more affordable for patients. However, prices may vary depending on the generic manufacturer, location, and insurance coverage. Patients should consult their healthcare providers or pharmacy for accurate pricing information [5].

References

[1] DrugPatentWatch.com - Xarelto (rivaroxaban) patents (as of Dec 2023)
[2] FDA approves Mylan's generic version of Xarelto for atrial fibrillation prevention (Feb 2020)
[3] Teva and Mylan gain FDA approval for Xarelto generic versions (Feb 2020)
[4] Why didn't Bayer and Janssen challenge generic Xarelto versions in court?
[5] Generic Xarelto pricing information (varies by location and insurance)

Sources

1. www.drugpatentwatch.com
2. FDA news release (Feb 2020)
3. Mylan press release (Feb 2020)
4. Teva press release (Feb 2020)
5. Generic pharmaceutical pricing information (varies)